Navigation Links
Bosoley Solar Light Set to Bring Haiti Out of the Post-Earthquake Darkness
Date:3/23/2010

position: outside; list-style-image: url(/images_v4/bullet_solid2.gif); padding-left: 0.5em; margin-left: 0.5em; line-height: 1.5em;">
  • Plug-and-play lighting kits for homes, camping activities, field hospitals, and emergency relief efforts.
  • User-friendly, maintenance-free, and multi-functional lights that can outfit communities for the long-term from Port au Prince to other affected cities.
  • Powerful stand alone solar powered floodlights to improve security wherever needed. These plug-and-play projectors can also be extremely useful for night patrols and off the grid areas.
  • Packages that contain prefabricated homes oufitted with solar powered lights for a reliable long-term housing solution. These homes are built to last and also available fully equipped.

  • Bosoley Solar Energy is a U.S.-based company founded by Haitians that has been dedicated to improving conditions in Haiti long before the earthquake. The company will re-invest 20% of the profits from all sales of its solar lights in an ongoing education program that will teach the Haitian people about the benefits of using solar lights over dangerous gas lanterns.

    Please visit us at www.bosoley.com for more information

    ###

    Read the full story at http://www.prweb.com/releases/2010/03/prweb3750674.htm.


    '/>"/>
    Source: PRWeb
    Copyright©2010 Vocus, Inc.
    All rights reserved  

    Page: 1 2

    Related medicine news :

    1. Inspired Solar Technologies (IST) Names James E. Green as CEO
    2. SolarAegis, LLC. Website Helps You Have Fun In the Sun, Safely
    3. COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology
    4. VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency
    5. Review Spotlights Clues to Serious Childhood Infection
    6. New Red Cross PSA Highlights Haiti Relief and Features Music by John Mayer
    7. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
    8. President Obama Highlights Bipartisan Policy Center Health Care Reform Plan in Remarks to House Republicans
    9. New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men
    10. Study highlights lack of patient knowledge regarding hospital medications
    11. Major Imaging Initiative to Shed Light on Little Known Brain Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    Bosoley Solar Light Set to Bring Haiti Out of the Post-Earthquake Darkness 
    (Date:9/30/2014)... Amy Norton HealthDay ... -- Long-acting contraceptive devices should be the first choice ... the American Academy of Pediatrics state. Although most ... two other forms of contraception -- intrauterine devices (IUDs) ... to the academy. And they should be the ...
    (Date:9/30/2014)... VA (PRWEB) September 30, 2014 Visit ... of Chestnut Hill and you will find a loving ... together, Amyotrophic Lateral Sclerosis. , Steve was ... or Lou Gehrig’s Disease – just before the couple’s ... primary caregiver. , A new video, “Care, Support ...
    (Date:9/30/2014)... Franklin, TN (PRWEB) September 30, 2014 ... millions of people throughout the United States and ... of Parkinson’s Disease are diagnosed each year, adding ... diagnosed with the disease. Approximately 400,000 people in ... 2.3 million worldwide. Add to these statistics the ...
    (Date:9/30/2014)... 2014 Pivotal 5, LLC, a proven ... Life Time – The Healthy Way of Life CompanySM ... KettleWorX Group Training . KettleWorX Group Training is a ... offers consumers of all fitness levels a means to ... manner. The rollout to Life Time Athletic destinations will ...
    (Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, 2014 (HealthDay ... the return of a common type of irregular heartbeat known ... percent of those taking fish oil for its omega-3 fatty ... of 16 months, compared to 63.2 percent of those ... the twin ills of inflammation or oxidative stress, which may ...
    Breaking Medicine News(10 mins):Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 2Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 3Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 3
    ... School of Medicine and colleagues discovered that the Notch ... types, and is also implicated in some cancers, is ... The findings appear this week in Cell Stem Cell, ... bone marrow stem cells. , Notch is one of ...
    ... the Head and Neck, NEW YORK, April 10 ... plastic and cosmetic surgery for the ethnic,patient, will speak ... day,Continuing Medical Education (CME) Accredited seminar entitled "Patient,Safety in ... 12 at the,University Club of New York., "Facial ...
    ... Support Event, ALEXANDRIA, Va., April 10 ... (NHDD), will be the largest,effort ever undertaken to ... "With healthcare, ,your decisions matter;, however, others ... Nathan A. Kottkamp, Chair, National,Healthcare Decisions Day. "All ...
    ... in wine that protect against dementia. This is shown in ... Sweden. , The findings are based on 1,458 women who ... 1968. When they were examined by physicians they were asked ... by selecting from seven categories on a scale from never ...
    ... - 7,000 deaths a year ... pharmacy error risk, - Half of consumers choose their pharmacies for ... ... One-third of America,s 225,million prescription-takers now report experiencing a prescription ...
    ... their children to a podiatrist,for foot ailments, BETHESDA, ... bring thousands of adults to doctors, offices every,day. But ... Medical Association (APMA) during April,s Foot Health Awareness,Month, many ... it comes to their children,s feet. In fact, only ...
    Cached Medicine News:Health News:Developing cancer treatments directed at critical developmental pathway 2Health News:Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar 2Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Wine may protect against dementia 2Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 2Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 3Health News:Pediatric Survey Reveals Many Parents Neglect Their Children's Feet 2
    (Date:9/30/2014)... Sept. 30, 2014 CytRx Corporation (NASDAQ: ... development company specializing in oncology, today announced the ... evaluating aldoxorubicin compared to topotecan in subjects with ... relapsed or were refractory to prior chemotherapy. Aldoxorubicin ... agent, doxorubicin. CytRx has received Orphan Drug Designation ...
    (Date:9/29/2014)... Fla. and DUBLIN , ... ("we" or the "Company"), a biotechnology company pioneering the ... marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections ... to its shareholders from CEO Noreen Griffin The letter ... Inc. (the "Company" or "TNIB") received a number of ...
    (Date:9/29/2014)... , Sept. 29, 2014  Moberg ( www.moberg.com ... CNS Monitor, a medical device used for advanced ... Mark certifies that a product has met European ... Europe . The CNS Monitor ... (EEG, or brain waves) to support neurological patient ...
    Breaking Medicine Technology:CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2
    ... Annual Meeting- , , ... of a randomized phase III study presented at the ... The study in adult patients with hematological malignancies at ... demonstrated that Elitek(R) (rasburicase) significantly reduced plasma uric acid ...
    ... Analgesic Significantly Reduces Postop Pain, Opioid Use, and ... Standard Pain Medication , ... A Phase II dose escalation study of a ... who underwent total knee arthroplasty, or TKA, showed ...
    Cached Medicine Technology:Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 4
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: